Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001131

Drug Information
SynonymsNCGC00168775-01; DB00496; CID444031; STOCK6S-73577; Darifenacin; D03654; CHEBI:391960; MolPort-005-943-011; (S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide; 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide; Emselex; 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide; AC1L9FKY; Darifenacin (USAN/INN); LS-187359; CHEMBL1346; AC-302; 133099-04-4    
Trade NameEnablex; Emselex    
CompanyNorvatis Phamaceuticals Corporation    
IndicationUrinary incontinenceApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassUrinary antispasmodics    
CAS NumberCAS 133099-04-4
PubChem Compound IDCID 444031.    
PubChem Substance IDSID 7979027.    
TargetMuscarinic acetylcholine receptor M3Antagonist[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2M(1) and M(3) muscarinic receptors are involved in the release of urinary bladder-derived relaxant factor. Pharmacol Res. 2009 May;59(5):300-5. Epub 2009 Feb 5. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543